A robust neutralization test for Plasmodium falciparum malaria.
Saul
A
A
Malaria Vaccine Development Unit, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, USA. ASaul@niaid.nih.gov
Miller
L H
LH
D000595:Amino Acid Sequence; D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology*; D000953:Antigens, Protozoan / Q000276:immunology*; D006801:Humans; D017780:Malaria Vaccines; D016778:Malaria, Falciparum / Q000276:immunology / Q000628:therapy*; D020066:Merozoite Surface Protein 1 / Q000235:genetics / Q000276:immunology; D008969:Molecular Sequence Data; D021261:Parasitic Sensitivity Tests / Q000379:methods*; D010963:Plasmodium falciparum / Q000276:immunology*; D017386:Sequence Homology, Amino Acid
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D017780:Malaria Vaccines; D020066:Merozoite Surface Protein 1